Evidence map›Paper›PMID 20809095›Full record

ArticlePediatric radiology2011

Advancing molecular imaging: a chairman's perspective on how radiology can meet the challenge.

Hedvig Hricak

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric radiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hedvig HricakDepartment of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. muellnea@mskcc.org

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, most molecular imaging techniques applied clinically have offered relatively general information about the metabolism and physiology of diseased cells and tissues. However, due to recent scientific and technological advances, much more specifically targeted molecular imaging probes (e.g., reporter gene probes, whole cell-tracking probes, and probes for localizing specific biomolecules) are now being used in preclinical research and, in some cases, translated to the clinical setting. As a result, the imaging community is poised to help lead a revolution in personalized, molecularly targeted medicine. This article considers the importance of molecular imaging for advancing research and clinical care both within individual institutions and across the medical field. It outlines specific steps that leaders in academic radiology can take to hasten progress in molecular imaging and explains why they must have the courage to reach across traditional interdisciplinary boundaries and advocate for major investments in equipment, education, and personnel.

Indexed as

ForecastingChildHumansMolecular ImagingRadiologyRadionuclide Imaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.